CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-20 | Scadden David Director | Option exercise | +1,585 | 7,120 | ||
| 2022-05-20 | Scadden David Director | Option exercise · Restricted stock unit | −1,585 | 0 | ||
| 2022-05-20 | CLARK IAN T Director | Option exercise | +1,585 | 6,549 | ||
| 2022-05-20 | CLARK IAN T Director | Option exercise · Restricted stock unit | −1,585 | 0 | ||
| 2022-05-20 | Schenkein David P Director | Option exercise | +1,585 | 117,879 | ||
| 2022-05-20 | Schenkein David P Director | Option exercise · Restricted stock unit | −1,585 | 0 | ||
| 2022-05-20 | Ho Maykin Director | Option exercise | +1,585 | 6,549 | ||
| 2022-05-20 | Ho Maykin Director | Option exercise · Restricted stock unit | −1,585 | 0 | ||
| 2022-05-20 | MARAGANORE JOHN Director | Option exercise | +1,585 | 30,028 | ||
| 2022-05-20 | MARAGANORE JOHN Director | Option exercise · Restricted stock unit | −1,585 | 0 | ||
| 2022-05-20 | Foster-Cheek Kaye I Director | Option exercise | +1,585 | 8,749 | ||
| 2022-05-20 | Foster-Cheek Kaye I Director | Option exercise · Restricted stock unit | −1,585 | 0 | ||
| 2022-04-08 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Stock options (right to buy) | +170,000 | 170,000 | ||
| 2022-04-08 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Restricted stock units | +47,800 | 47,800 | ||
| 2022-03-01 | Biller Jonathan Chief Financial Officer | Grant or award · Restricted stock units | +11,500 | 11,500 | ||
| 2022-03-01 | Biller Jonathan Chief Financial Officer | Grant or award · Stock options (right to buy) | +41,000 | 41,000 | ||
| 2022-03-01 | Car Bruce Chief Scientific Officer | Grant or award · Restricted stock units | +11,500 | 11,500 | ||
| 2022-03-01 | Car Bruce Chief Scientific Officer | Grant or award · Stock options (right to buy) | +41,000 | 41,000 | ||
| 2022-03-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Restricted stock units | +11,500 | 11,500 | ||
| 2022-03-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Stock options (right to buy) | +41,000 | 41,000 |
Page 35 of 48 · 941 trades